MMC
XBI icon

Mizuho Markets Cayman’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mizuho Markets Cayman’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-636
Closed -$63.7K – 136
2025
Q3 		$63.7K Buy
+636
New +$57.3K 0.01% 80

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Mizuho Markets Cayman's XBI Position: Q4 2025 in Review

Mizuho Markets Cayman sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 636 shares — an estimated $63.7K sold.

Mizuho Markets Cayman first reported a position in XBI in Q3 2025 and held it in 1 quarter. The position peaked at $63.7K in Q3 2025. 815 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • Mizuho Markets Cayman reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Mizuho Markets Cayman sold 636 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $63.7K.
  • Mizuho Markets Cayman first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and held it in 1 quarter.
  • Mizuho Markets Cayman's State Street SPDR S&P Biotech ETF position peaked at $63.7K in Q3 2025.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Mizuho Markets Cayman's 13F filing for Q4 2025, filed 6 Feb 2026.